Home > Weight Loss Peptide

Weight Loss Peptide

Palatin Technologies Inc. (NYSE: PT-141) announced today that it has shown positive results in a Phase I clinical trial of pT-141 for the treatment of sexual dysfunction in normal premenopausal women. The trial included 32 healthy female volunteers and evaluated their response to pT-141 and placebo in response to visual stimuli. Pt-141 was found to be safe and resulted in a significantly greater improvement in vaginal blood flow than placebo users (P< 0.05). role Such antibiotics first affect the outer membrane of sensitive bacteria. Drug ring part of polypeptide amino and lipopolysaccharide in the outer membrane 2 valence cations combining site to produce electrostatic interaction, destroy the integrity of the outer membrane damage

Company Video
Related Youtube Videos
  • 51bd75535cad6dec86248526e429d7fe.mp4
  • white

Certification

QUALITY MANAGEMENT SYSTEM CERTIFICATE
Production Safety certificate
business permit
 letters patent

Certification

QUALITY MANAGEMENT SYSTEM CERTIFICATE
Production Safety certificate
business permit
 letters patent
Industry Information
Industry Information
  • Polypeptides are complex macromolecules, so each sequence is unique in both physical and chemical properties. Some peptides are difficult to synthesize, while others are relatively easy to synthesize, but purification is difficult. The most common...

  • “The prospects for the development of pharmaceutical intermediates in China are still promising.” This is the information that the reporter learned from the experts at the second seminar on pharmaceutical intermediates R&D progress and market...

Home > Weight Loss Peptide
Contact Now

Contact

  • Tel: 86--13109615273
  • Address: Building 13, Jinxiuguandi, Biyuan Road, Qindu District, Xianyang, Shaanxi China

Send Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send